The quality of life of epileptic patients

Main Article Content

Harsono Harsono

Abstract

Epilepsy has historically been surrounded by prejudice and myth, and associated with many misconceptions. Even today, people with epilepsy experience psychosocial problems, especially in their relationships and employment. Age, seizure severity and frequency, stigma of epilepsy, social deprivation, fear and anxiety, factors responsible for inadequate treatment, treatment gap, and healthcare needs may affect the quality of life of epileptic patients. Improving the diagnosis, treatment, prevention, and social acceptability are important factors in achieving the objective of the management of epilepsy. Treatment of epilepsy refers to any intervention that is intended to restore health status including quality of life. Quality of life is recognized as an important outcome in epilepsy treatment. Quality of life has been reported to vary across epileptic patients with different clinical, demographic, and socio-economic variables. Seizure type and frequency have been found to be significant predictors of quality of life scores. For measuring quality of life in clinical practice, such as in epileptic patients, a wider range of properties is required to ensure that a measure can be used routinely. These include validity, appropriateness and acceptability, reliability, responsiveness to change, and interpretability.

Article Details

How to Cite
Harsono, H. (2008). The quality of life of epileptic patients. Universa Medicina, 27(4), 194–203. https://doi.org/10.18051/UnivMed.2008.v27.194-203
Section
Review Article

References

Espie CA, Watkins J, Curtice L, Espie A, Duncan R, Ryan J, et al. Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables. J Neurol Neurosurg Psychiatry 2003; 74: 1485-92.

Cyrlac N, Sureskumar PN, Kunhikoyamu AM, Girija AS. Social factors and psychopathology in epilepsy. Neurol India 2002; 50: 153-57.

Bishop M, Berven NL, Hermann BP, Chan F. Quality of life among adults with epilepsy: an exploratory model. Rehabil Couns Bull 2002; 45: 87-95.

Wiebe S, Matijevic S, Eliasziw M, Derry PA. Clinically important change in quality of life in epilepsy. J Neurol Neurosurg Psychiatry 2002; 73: 116-20.

Djibuti M, Shakarishvili R. Influence of clinical, demographic, and socioeconomic variables on quality of life in patients with epilepsy: findings from a Georgian study. J Neurol Neurosurg Psychiatry 2003; 74: 570-73.

Herodes M, Oun A, Haldre S, Kaasik AE. Epilepsy in Estonia: a quality of life study. Epilepsia 2001; 42: 1061-73.

Shafer PO. Improving the quality of life in epilepsy. Postgrad Med 2002; 111: 1. Available at: http://www.postgradmed.com/issues/2002/01_02/shafer.htm 10/18/2004. Accessed September 2, 2008.

Bishop M, Allen CA. The impact of epilepsy on quality of life: A qualitative analysis. Epilepsy Behav 2003; 4: 226-33.

Meinardi H, Scott RA, Reis R, Sander JWAS. ILAE Commission report: The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 2001; 42:136-49.

Reynolds EH. The ILAE/IBE/WHO epilepsy global campaign history: International League Against Epilepsy – International Bureau for Epilepsy. Epilepsia 2002; 43:9-11.

Stavem K, Loge JH, Kaasa S. Health status of people with epilepsy compared with the general reference population. Epilepsia 2000; 41: 85-90.

Boylan LS, Flint LA, Labovitz DL, Jackson SC, Starner K, Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004; 62: 258-61.

Leidy NK, Elixhauser A, Vickrey B, Means E, Willian MK. Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology 1999; 53: 162-66.

Higginson IJ, Carr AJ. Measuring quality of life: using quality of life measures in the clinical setting. BMJ 2001; 322: 1297-300.

Ventegodt S, Merrick J, Andersen NJ. Measurement of quality of life III. From the IQOL theory to the global, generic SEQOL questionnaire. Sci World J 2003; 3: 972-91.

Cramer JA, Arrigo C, Van Hammee, Gauer LJ, Cereghino JJ. Effect of levetiracetam on epilepsy-related quality of life. Epilepsia 2000; 41: 868-74.

Mrabet H, Mrabet A, Zouari B, Ghachem R. Health-related quality of life of people with epilepsy compared with a general reference population: a Tunisian Study. Epilepsia 2004; 45: 838-43.

Malgren K. Epilepsy care across Europe and key concerns. Neurological Disorders: long-term healthcare strategies 2003; 44: 54-6.

American Epilepsy Society. Living well with epilepsy. Report of the national conference on public health and epilepsy; 1997.

Mielke J, Sebit M, Adamolekun B. The impact of epilepsy on quality of life of people with epilepsy in Zimbabwe: a pilot study. Seizure 2000; 9: 259-64.

Olley BO. Psychological and seizure factors related to depression and neurotic disorders among patients with chronic epilepsy in Nigeria. Afr J Med Sci 2004; 33: 39-44.

Mosaku KS, Fatoye FO, Komolafe M, Lawal M, Ola BA. Quality of life and associated factors among adults with epilepsy in Nigeria. Int Psychiatry Med 2006; 36: 469-91.

Morgan CLI, Ahmed Z, Kerr MP. Social deprivation and prevalence of epilepsy and associated health usage. J Neurol Neurosurg Psychiatry 2000; 69: 13-7.

Jacoby A, Buck D, Baker G, McNamee P, Graham-Jones S, Chadwick D. Uptake and costs of care for epilepsy: findings from a UK regional study. Epilepsia 1998; 39: 776-86.

Fisher RS, Vickrey BG, Gibson P, Hermann B, Penovich P, Scherer A, et al. The impact of epilepsy from the patient’s perspective I: descriptions and subjective perceptions. Epil Res 2000; 41: 39-51.

Austin JK. Concerns and fears of children with seizures. Clin Nurs Pract Epil 1993; 1: 4-10.

Scott RA, Lhatoo SD, Sander JWAS. The treatment of epilepsy in developing countries: where do we go from here? Bull WHO 2001; 79: 344-51.

Shorvon SD, Farmer PJ. Epilepsy in developing countries: a review of epidemiological, sociocultural and treatment aspects. Epilepsia 1988; 29: S36-45.

Watts AE. A model of managing epilepsy in a rural community in Africa. BMJ 1989; 298: 805-7.

Harsono. Seizure threshold, hormones and anti-epileptic drugs. Univ Med 2008; 27: 18-28.